Cargando…
Trimebutine Promotes Glioma Cell Apoptosis as a Potential Anti-tumor Agent
Gliomas are the most common primary brain tumors with a usually fatal malignancy. They are associated with a poor prognosis although multiple therapeutic options have been available. Trimebutine is one of the prokinetic agents and it has been mainly used for treatment of disorders of the gastrointes...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021541/ https://www.ncbi.nlm.nih.gov/pubmed/29977208 http://dx.doi.org/10.3389/fphar.2018.00664 |